Diversity and Multi-Target Potential of Pyrazole, Imidazole or Triazole Derivatives in Modern Anticancer Therapy

Area of Science:

• Medicinal Chemistry
• Drug Discovery
• Oncology

Background:

• Cancer treatment faces challenges including drug resistance, combination therapy toxicity, and lack of selectivity.
• Multi-target directed ligands (MTDLs) are emerging as a promising therapeutic strategy.
• Nitrogen-containing heterocycles are a rich source of potential MTDLs.

Purpose of the Study:

• To provide a comprehensive overview of novel multi-targeted derivatives of nitrogen-containing heterocycles for anticancer applications.
• To analyze the inhibitory activity, molecular targets, and binding interactions of these compounds.
• To discuss structure-activity relationships (SAR) to guide future drug development.

Main Methods:

• Literature review of selected studies from 2006 to 2026.
• Analysis of inhibitory potency against various molecular targets.
• Evaluation of interactions with protein binding sites and SAR studies.

Main Results:

• Identified novel imidazole, pyrazole, 1,2,3-triazole, and 1,2,4-triazole derivatives with potential anticancer activity.
• Detailed analysis of their potency, target interactions, and SAR.
• Compilation of data to support the development of new MTDLs.

Conclusions:

• Novel nitrogen-containing heterocyclic derivatives show significant potential as multi-target anticancer agents.
• Understanding SAR and target interactions is crucial for designing effective MTDLs.
• This review provides a foundation for developing next-generation cancer therapeutics.